Evidence map›Paper›PMID 22415451›Full record

ArticleInternational urology and nephrology2012

Paired exchange kidney donation in India: a five-year single-center experience.

Mrinal Pahwa, Yusuf Saifee, Vipin Tyagi, Sudhir Chadha, Harsh Jauhari

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Mrinal PahwaSir Ganga Ram Hospital, New Delhi, India. drmrinalpahwa@gmail.com
Yusuf Saifee
Vipin Tyagi
Sudhir Chadha
Harsh Jauhari

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPaired exchange kidney donation (PKD) is an evolving strategy for overcoming the barriers that confront patients with end-stage renal disease, when the only living potential donors who are willing to donate to them are deemed to be unsuitable as donors for them owing to an incompatibility of blood type, of HLA cross-match, or of both. In the PKD, the incompatibility problems with two donor recipient pairs can be solved by exchanging donors. Although PKD is increasing worldwide, we in India have not nearly reached the estimated potential of this modality. Herein, we have reported our results with a living donor exchange program in past 5 years. MATERIALS AND

methodsBetween March 2006 and June 2011, we performed 44 living PKD transplantations. All donor and recipient procedures were performed successfully. ABO incompatibility or positive lymphocyte cross-match were found in 20 pairs and 2 pairs, respectively.

resultsThe mean recipient age was 42.5 years (range 33-59 years). The mean donor age was 38 years (range 31-56 years). At a median follow-up of 33 months (range 1-59 months), graft survival rate was 100 %. All patients have functioning grafts with a median serum Creatinine level of 1.13, 1.5, and 1.35 mg/dl at 3 month, 1 year, and 3 years, respectively. One patient died after 4 month of transplant due to pneumonitis with sepsis. Allograft dysfunction was not seen in any of the recipients.

conclusionThe PKD transplantation is a viable procedure medically and economically, which can be promoted in centers with a low deceased donor transplantation rate and a high number of incompatible related donors. We achieved excellent graft outcome by using the PKD transplantation program as an option to reduce the donor organ shortage.

Indexed as

AdultFemaleFollow-Up StudiesGraft SurvivalHumansIncidenceIndiaKidney Failure, ChronicKidney TransplantationLiving DonorsMaleNephrectomyRetrospective StudiesTime FactorsTissue and Organ Procurement

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.